Validation study of automated oscillometric measurement of the ankle-brachial index for lower arterial occlusive disease by comparison with computed tomography angiography
Abstract:The ankle-brachial index (ABI) determined by the oscillometric method has been shown to reliably detect peripheral arterial disease (PAD), with highly correlations with the Doppler method. However, most of these studies were shown in cohorts with a small number of PAD patients, and no imaging studies have been performed. The purpose of this study is to evaluate the diagnostic accuracy and optimal threshold of oscillometric ABI for detecting PAD using computed tomography angiography (CTA) as a gold standard in … Show more
“…In ours, only the Doppler ABI calculation based in standard formulas or not and diabetes achieved statistical significance in dOR to explain heterogeneity, in such a way that those studies with a standard Doppler calculation and those with a low prevalence of diabetes exhibited higher values of dOR. These findings emphasise the lack of accuracy of the oscillometric ABI in diabetic patients, as has been previously reported in studies using both ultrasound and angiographic confirmation . As meta‐regression analyses suggested, this lack of accuracy especially occurs at the expense of sensitivity, which emphasises the use of cut‐off values greater than 0.9 for diabetic patients (values between 1.0 and 1.1 have been suggested) .…”
Section: Discussionsupporting
confidence: 57%
“…previously reported in studies using both ultrasound and angiographic confirmation. 48,49 As meta-regression analyses suggested, this lack of accuracy especially occurs at the expense of sensitivity, which emphasises the use of cut-off values greater than 0.9 for diabetic patients (values between 1.0 and 1.1 have been suggested). 48 The physiological explanation seems to be calcification, which turns the artery wall rigid and poorly compressible, making ABI less reliable, especially for the oscillometric method.…”
Summary
Introduction
Peripheral arterial disease (PAD) remains underdiagnosed and undertreated, partly because of limitations in the Doppler ankle‐brachial index (ABI), the non‐invasive gold standard.
Objective
This systematic review and meta‐analysis aims to compare the diagnostic accuracy of the oscillometric ABI and the Doppler ABI, and to examine the influence of two approaches to analysis: legs vs subjects and inclusion of oscillometric errors as PAD equivalents vs exclusion.
Methods
Systematic searches in EMBASE, MEDLINE, Web of Science and the Cochrane Library databases were performed, from inception to February 2017. Random‐effects models were computed with the Moses‐Littenberg constant. Hierarchical summary receiver operating characteristic curves (HSROC) were used to summarise the overall test performance.
Results
Twenty studies (1263 subjects and 3695 legs) were included in the meta‐analysis. The pooled diagnostic odds ratio (dOR) for the oscillometric ABI was 32.49 (95% CI: 19.6‐53.8), with 65% sensitivity (95% CI: 57‐74) and 96% specificity (95%CI: 93‐99). In the subgroup analysis, the “per subjects” group showed a better performance than the “per legs” group (dOR 36.44 vs 29.03). Similarly, an analysis considering oscillometric errors as PAD equivalents improved diagnostic performance (dOR 31.48 vs 28.29). The time needed for the oscillometric ABI was significantly shorter than that required for the Doppler ABI (5.90 vs 10.06 minutes, respectively).
Conclusions and relevance
The oscillometric ABI showed an acceptable diagnostic accuracy and feasibility, potentially making it a useful tool for PAD diagnosis. We recommend considering oscillometric errors as PAD equivalents, and a “per subject” instead of a “per leg” approach, in order to improve sensitivity. Borderline oscillometric ABI values in diabetic population should raise concern of PAD.
“…In ours, only the Doppler ABI calculation based in standard formulas or not and diabetes achieved statistical significance in dOR to explain heterogeneity, in such a way that those studies with a standard Doppler calculation and those with a low prevalence of diabetes exhibited higher values of dOR. These findings emphasise the lack of accuracy of the oscillometric ABI in diabetic patients, as has been previously reported in studies using both ultrasound and angiographic confirmation . As meta‐regression analyses suggested, this lack of accuracy especially occurs at the expense of sensitivity, which emphasises the use of cut‐off values greater than 0.9 for diabetic patients (values between 1.0 and 1.1 have been suggested) .…”
Section: Discussionsupporting
confidence: 57%
“…previously reported in studies using both ultrasound and angiographic confirmation. 48,49 As meta-regression analyses suggested, this lack of accuracy especially occurs at the expense of sensitivity, which emphasises the use of cut-off values greater than 0.9 for diabetic patients (values between 1.0 and 1.1 have been suggested). 48 The physiological explanation seems to be calcification, which turns the artery wall rigid and poorly compressible, making ABI less reliable, especially for the oscillometric method.…”
Summary
Introduction
Peripheral arterial disease (PAD) remains underdiagnosed and undertreated, partly because of limitations in the Doppler ankle‐brachial index (ABI), the non‐invasive gold standard.
Objective
This systematic review and meta‐analysis aims to compare the diagnostic accuracy of the oscillometric ABI and the Doppler ABI, and to examine the influence of two approaches to analysis: legs vs subjects and inclusion of oscillometric errors as PAD equivalents vs exclusion.
Methods
Systematic searches in EMBASE, MEDLINE, Web of Science and the Cochrane Library databases were performed, from inception to February 2017. Random‐effects models were computed with the Moses‐Littenberg constant. Hierarchical summary receiver operating characteristic curves (HSROC) were used to summarise the overall test performance.
Results
Twenty studies (1263 subjects and 3695 legs) were included in the meta‐analysis. The pooled diagnostic odds ratio (dOR) for the oscillometric ABI was 32.49 (95% CI: 19.6‐53.8), with 65% sensitivity (95% CI: 57‐74) and 96% specificity (95%CI: 93‐99). In the subgroup analysis, the “per subjects” group showed a better performance than the “per legs” group (dOR 36.44 vs 29.03). Similarly, an analysis considering oscillometric errors as PAD equivalents improved diagnostic performance (dOR 31.48 vs 28.29). The time needed for the oscillometric ABI was significantly shorter than that required for the Doppler ABI (5.90 vs 10.06 minutes, respectively).
Conclusions and relevance
The oscillometric ABI showed an acceptable diagnostic accuracy and feasibility, potentially making it a useful tool for PAD diagnosis. We recommend considering oscillometric errors as PAD equivalents, and a “per subject” instead of a “per leg” approach, in order to improve sensitivity. Borderline oscillometric ABI values in diabetic population should raise concern of PAD.
“…The AngSc is negatively correlated with maximum treadmill walking distance 12 and ankle-brachial pressure index (ABPI), 13 which is a functional measure of the severity of PAD. 14 Furthermore, AngSc is an independent risk factor for major amputation in diabetic subjects with PAD. 15 Previous studies have shown that PAD is associated with metabolic dysbalances 16 and AS.…”
Arterial stiffness is an independent determinant of cardiovascular risk and a marker of subclinical organ damage. Metabolomics may facilitate identification of novel low-molecular cardiovascular risk factors. The aim of the present study was to compare metabolic signatures and functional-biochemical characteristics of patients with peripheral arterial disease (PAD) and clinically healthy subjects. We studied 42 men with symptomatic PAD (aged 66±7 years) and 46 healthy men (aged 66±8 years). Aortic pulse wave velocity (aPWV) was assessed by applanation tonometry using the Sphygmocor device. Metabolic profiling was performed with high-performance liquid chromatography and mass spectrometry. Serum oxidized low-density lipoprotein (oxLDL) level was measured by enzyme-linked immunosorbent assay. The aPWV as well as serum levels of lactate, free carnitine and 11 amino acids including tyrosine were higher among the patients with PAD. In contrast, serum levels of pyruvate, citrate, α-ketoglutarate, aconitate and cysteine were higher in the control group. In multiple regression models, aPWV was independently determined by log-tyrosine and log-oxLDL in the patients (R(2)=0.61; P<0.001) and by age, log-pyruvate and log-oxLDL in the controls (R(2)=0.52; P<0.001). Our study describes for the first time significant differences in metabolomic signature of patients with advanced atherosclerosis compared with clinically healthy controls. The aPWV is independently associated with serum levels of tyrosine and oxLDL in the patients with PAD and is related to pyruvate and oxLDL levels in the control group. The measurement of low-molecular metabolites, which are related to changes in vascular phenotypes, may lead to identification of novel vascular risk markers.
“…However, several publications have advised to use ABI ≤1 for oscillometric techniques. 14 – 17 In that case, MESI device reached 85% of sensitivity and 96% specificity to detect PAD in at least one leg.…”
Section: Resultsmentioning
confidence: 84%
“… 18 However, several authors have reported that using a cutoff value closer to 1 was better to diagnose PAD surely because of the systematic small overestimation of oscillometric method. 14 – 17 When using 1 as a cutoff value, the MESI ABPI MD device sensitivity was 85% and 96% for specificity showing excellent detection of PAD. In our study, PAD diagnosis was solely based on Doppler ABI results.…”
In occidental countries, peripheral arterial disease (PAD) is an important health issue; however, most subjects are asymptomatic (~50%) and therefore undiagnosed and untreated. Current guidelines recommend screening for PAD in primary care setting using ankle brachial index (ABI) in all patients with cardiovascular risks. This is, however, not performed strictly because the standard Doppler method is cumbersome and time-consuming. Here, we evaluate the accuracy and reproducibility of ABI measurements obtained by an improved automated oscillometric device, the MESI ABPI MD® device, and the standard Doppler method. ABI was measured in random order in a general practice with Doppler probes by two operators separately (ABI_dop) and twice with the MESI ABPI MD device (ABI_mesi). ABI_dop was calculated dividing the highest systolic blood pressure from both tibial and dorsalis pedis arteries by the highest systolic blood pressure of both brachial arteries. ABI_mesi was obtained automatically with simultaneous measurements on three extremities. According to ABI_dop, PAD was present in 10% of the 136 screened subjects (68.2±7.4 years). Interoperator coefficient of variation was 5.5% for ABI_dop, while the intrasubject coefficient of variation for ABI_mesi was 3.0%. ABI_mesi was correlated with ABI_dop (R=0.61, P<0.0001). The difference between the two techniques was 0.06±0.14 with ABI_mesi providing slightly higher values (P<0.0001) and negligible bias across the range (R=0.19, P<0.0001). Therefore, ABI_mesi ≤1 had a sensitivity of 85% and specificity of 96% to detect ABI_dop ≤0.9 and hence PAD. Doppler measurements took seven times longer than MESI ABPI MD measurements to be performed. In conclusion, MESI improved automated oscillometric method and offered a faster and repeatable measurement of ABI with only a small, clinically irrelevant overestimation of ABI value. The tested MESI ABPI MD-improved oscillometric system can be used as a screening tool for patients in general practice and would enable family doctors to comply with current guidelines for PAD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.